drugset / Trial / NCT06755099

Female Sexual Dysfunction Assessment and Managment of Vaginismus

NCT06755099

Phase 2/3 Not yet recruiting 40 enrolled Assiut University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The study aims at : 1. The extent female sexual dysfunction problem in community through questionnaire . 2. Compare effectiveness of two treatment options for vaginismus .

Timeline

Start
2025-01-01
Primary completion
2026-08-30
Completion
2026-11-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 50 iu Other

Indications